Media tour conducted in conjunction with D S Simon Media discussing Peripheral Artery Disease (PAD), one of the most prevalent diseases that no one has heard of, affecting one in 20 Americans over the age of 50
Media tour conducted in conjunction with D S Simon Media discussing Peripheral Artery Disease (PAD), one of the most prevalent diseases that no one has heard of, affecting one in 20 Americans over the age of 50
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) —
There is a “silent epidemic” affecting millions in the U.S. and disproportionately affecting Black and Hispanic communities. It is a leading cause of preventable amputations yet remains relatively unknown.
That epidemic is Peripheral Artery Disease or PAD, a condition where blood flow is reduced to lower limbs, leading to severe complications, including chronic pain, reduced mobility, and, in extreme cases, amputation. Despite its seriousness, PAD is frequently overshadowed by other health conditions.
Other treatment options exist, yet too often, amputations are the first course of treatment.
- 70% of Americans are not familiar with PAD, leading to dire consequences.
- 400 people get PAD related amputations every day in the U.S.
- Each year, 150,000 PAD related amputations are performed in the U.S.
By shedding light on PAD, your station can play a pivotal role in raising awareness of the issue locally and encouraging proactive health measures among your audience.
On September 30th a media tour was conducted in conjunction with D S Simon Media featuring Dr. Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business and founding member of the Diversity in Research Office at Abbott.
Topics that were discussed included:
- Signs and symptoms of Peripheral Artery Disease (PAD)
- How many people are affected by it each year and why there is a lack of understanding about the condition
- Why PAD disproportionately affects the Black and Hispanic communities
- What are the treatment options available about PAD
- Resources and information
For more information, visit pad-info.com
About D S Simon Media
The firm is well known as a leader in the satellite media tour industry and produces tours from its studio and multiple control rooms at its New York headquarters. Clients include top brands in healthcare, technology, travel, financial services, consumer goods, entertainment, retail and non-profits. Established in 1986 the firm has won more than 100 industry awards.
Dante Muccigrosso
Director of Media Integration & Client Reporting
E: dantem@dssimon.com
C: 973.524.0104
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/04aeba41-8a9d-44b4-be81-a965e49cb8a1
- TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma - December 8, 2024
- Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML - December 8, 2024
- Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma - December 8, 2024